(Press-News.org) ANN ARBOR, Mich. -- Concerns about fertility kept a third of young women with breast cancer from taking tamoxifen, despite its known benefit in reducing the risk of breast cancer coming back.
In addition, the study found fertility concerns led a quarter of women who started tamoxifen to stop taking it before the recommended treatment period ended.
"Our study points toward the importance of fertility to young breast cancer patients. We need to find a way to bridge the gap between this patient survivorship goal and our concerns as physicians to facilitate the best treatment possible for our patients," says senior study author Jacqueline Jeruss, M.D., Ph.D., associate professor of surgery and biomedical engineering at the University of Michigan and a breast cancer surgeon at the University of Michigan Comprehensive Cancer Center.
The study, published in the Journal of the National Cancer Institute, looked at the electronic medical records of 515 premenopausal women treated for breast cancer at Northwestern Memorial Hospital's Lynn Sage Comprehensive Breast Center. All patients who were included had estrogen receptor- or progesterone receptor-positive breast cancer and were recommended to take tamoxifen.
Previous studies have shown that five years of tamoxifen can reduce recurrence risk by 47 percent and mortality by 26 percent. More recent data suggests continuing tamoxifen for 10 years may be even more beneficial in preventing recurrence or death.
In the current study, researchers found that 13 percent of patients declined to take tamoxifen and 16 percent stopped before the five years of recommended treatment were up. Of those who declined, the most common factors were a diagnosis of ductal carcinoma in situ, declining radiation therapy, not receiving chemotherapy and expressing a desire for future fertility. A desire for future fertility was also significantly associated with the early discontinuation of tamoxifen.
The researchers also conducted phone interviews with 88 patients who did not initiate or discontinued tamoxifen to help confirm the findings obtained from patient records. Concerns about fertility and side effects were the primary factors patients mentioned as influencing their decisions about taking or staying on tamoxifen.
"This study shines a bright light on the fertility concerns of young cancer patients. Through the Oncofertility National Physicians Cooperative program, fertility concerns for young cancer patients can now be addressed. If provided at the time of diagnosis, this may ensure more young women with a cancer diagnosis adhere to their life-preserving tamoxifen treatments," said Teresa K. Woodruff, Ph.D., director of the Oncofertility Consortium, based at Northwestern University Feinberg School of Medicine.
Women taking tamoxifen are advised to avoid pregnancy because of the high potential for harm to the baby. The authors emphasize the need to provide additional counseling and education to patients who may be at higher risk for declining tamoxifen.
"For those oncology patients who express a desire for future fertility or a concern about fertility preservation, appropriate counseling and referral to a fertility specialist should be offered at the outset as part of a multidisciplinary treatment plan. We should work toward a dialogue where patients can discuss with their physicians issues that are important to them. By creating such a dialogue, we may identify more patients who are willing to complete the recommended course of tamoxifen therapy, though this may involve a treatment delay or hiatus to allow for a pregnancy," Jeruss says.
A new international trial is currently looking at whether premenopausal women who stop tamoxifen for a period of time to become pregnant and then resume tamoxifen after pregnancy have similar benefit as those who have a continuous course of tamoxifen. This trial, called POSITIVE, is being conducted by the International Breast Cancer Study Group. In addition, several options exist for preserving fertility before treatment begins, although these procedures may not be covered by insurance. For information, call the U-M Cancer AnswerLine at 800-865-1125.
INFORMATION:
Additional authors: Natalia C. Llarena and Samantha L. Estevez, from Northwestern University; Susan L. Tucker, from M.D. Anderson Cancer Center
Funding: National Institute of Child Health and Human Development grant P50 HD076188 and Northwestern University's Medical Student Summer Research Program
Disclosure: None
Reference: Journal of the National Cancer Institute, doi:10.1093/jnci/djv202, published online Aug. 24, 2015
Resources:
U-M Cancer AnswerLine, 800-865-1125
U-M Comprehensive Cancer Center, http://www.mcancer.org
Clinical trials at U-M, http://www.mcancer.org/clinicaltrials
mCancerTalk blog, http://uofmhealthblogs.org/cancer
HOUSTON - (Aug. 24, 2015) - Electronic triggers designed to search for key data, developed by researchers at Baylor College of Medicine and Michael E. DeBakey Veterans Affairs Medical Center, were able to identify and reduce follow-up delays for patients being evaluated for a diagnosis of colon or prostate cancer.
The full study can be found in the Journal of Clinical Oncology.
"Our computerized triggers scanned huge amounts of patient data in the electronic health record and flagged individuals at risk for delays in follow-up of cancer-related abnormal clinical findings," ...
Danny has become a degenerate, that is, the tropical depression weakened. Satellite and Hurricane Hunter aircraft data showed that Danny degenerated into an elongated area of low pressure near the Windward Islands during the afternoon (local time) on August 24. Meanwhile two other developing low pressure areas lie to the east of Danny.
Satellite data from NOAA's GOES-East satellite at 14:45 UTC (10:45 a.m. EDT) on August 24, showed Danny had become stretched out into a trough of low pressure. At 11 a.m. EDT (1500 UTC), the remnants of Danny were located near latitude ...
TALLAHASSEE, Fla. -- In the second part of his lab's recent one-two punch, Florida State University researcher Daniel Kaplan said he has solved a cell division mystery in a way that will intrigue the makers of cancer-fighting drugs.
The key, said Kaplan, a College of Medicine Department of Biomedical Sciences researcher, is a protein called Treslin.
"It can target cancer cells," he said. "Most chemotherapy also targets rapidly dividing normal cells, but this seems to have promise for not doing that. Drug companies are going to be excited."
Before cells can divide, ...
SAN DIEGO, Calif. -- (Aug. 24, 2015) -- A new survey on sexual victimization issues at the University of Oregon reaffirms previous findings that there is a need to increase awareness about available services, while decreasing negative perceptions of institutional support.
Psychology professor Jennifer Freyd provided preliminary findings of the UO survey at the 20th International Summit & Training on Violence, Abuse & Trauma during a keynote session on "Campus Sexual Assault: Current Research and Prevention Approaches."
New issues also surfaced among the key findings ...
CAMBRIDGE, Mass. (August 24, 2015) - By teasing apart the structure of an enzyme vital to the infectious behavior of the parasites that cause toxoplasmosis and malaria, Whitehead Institute scientists have identified a potentially 'drugable' target that could prevent parasites from entering and exiting host cells.
Although toxoplasmosis causes disease only in certain individuals-including immunocompromised patients, pregnant women, and their infants, the T. gondii parasite is closely related to Plasmodium, which causes malaria. Research on T. gondii can provide insights ...
Commonly used antidepressant drugs change levels of a key signaling protein in the brain region that processes both pain and mood, according to a study conducted at the Icahn School of Medicine at Mount Sinai and published August 24 in the Proceedings of the National Academy of Sciences (PNAS). The newly understood mechanism could yield insights into more precise future treatments for nerve pain and depression.
The study was conducted in mice suffering from chronic neuropathic pain, a condition which is caused in mice and humans by nerve damage. Chronic neuropathic ...
Bacteria are best known as free-living single cells, but in reality their lives are much more complex. To survive in harsh environments, many species of bacteria will band together and form a biofilm--a collection of cells held together by a tough web of fibers that offers protection from all manner of threats, including antibiotics. A familiar biofilm is the dental plaque that forms on teeth between brushings, but biofilms can form almost anywhere given the right conditions.
Biofilms are a huge problem in the health care industry. When disease-causing bacteria establish ...
Atlanta, GA - August 24, 2015 - Respiratory syncytial virus (RSV), which is the leading cause of childhood respiratory hospitalizations among premature babies, can be detected from the clothes worn by caregivers/visitors who are visiting infants in the neonatal intensive care unit (NICU), according to research being presented at the International Conference on Emerging and Infectious Diseases in Atlanta, Georgia.
"The aim of this study was to identify potential sources of transmission of RSV in the NICU to better inform infection control strategies," said Dr. Nusrat ...
Atlanta, GA - August 24, 2015 - Experts show that while Middle East Respiratory Syndrome (MERS-CoV), a viral respiratory illness, is infecting less people, it has a higher mortality rate and affects a specific target population when compared to Severe Acute Respiratory Syndrome (SARS-CoV). This research is being presented at the International Conference on Emerging and Infectious Diseases in Atlanta, Georgia.
"The research conducted in this study focuses on understanding what population of individuals are most likely to become infected by MERS-CoV, compared to the population ...
BEAUMONT -- Entomologists in Texas got a whiff of a new stink bug doing economic damage to soybeans in Texas and are developing ways to help farmers combat it, according to a report in the journal Environmental Entomology.
Various types of stink bugs have long been a problem on soybean crops, but when sweeps of fields in southeast Texas netted 65 percent redbanded stink bugs, entomologists realized this particular bug had become the predominant pest problem, according to Dr. Mo Way, an entomologist at the Texas A&M AgriLife Research and Extension Center in Beaumont.
The ...
